Background Mass indoor gatherings were banned in early 2020 to prevent the spread of
SARS-CoV-2. We aimed to assess, under controlled conditions, whether infection rates among …

While the coronavirus disease 2019 (COVID-19) pandemic has peaked in many countries
already, the current challenge is to assess population immunity on a large scale. Many …

Objectives Environmental contamination by patients with severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) through respiratory droplets suggests that surfaces and …

Background The World Health Organization (WHO) reported an outbreak of monkeypox virus
(MPXV) in Western countries on May 12 th , 2022. In early October, WHO counted 68 900 …

Rapid identification of SARS-CoV-2-infected individuals is a cornerstone for the control of
virus spread. The sensitivity of SARS-CoV-2 RNA detection by RT-PCR is similar in saliva and …

Nasopharyngeal sampling for nucleic acid amplification testing (NAAT) is the standard diagnostic
test of coronavirus disease 2019. Our objectives were to assess, in real-life conditions, …

Background The decision about whether to switch to third-line antiretroviral therapy (ART) in
patients with treatment failure on second-line therapy is difficult in settings with little access …

Limited access to nucleic acid testing (NAT) to quantify HBV DNA levels, an essential tool to
determine anti‐HBV treatment eligibility, represents a significant barrier to scale up HBV …

Objectives To determine the extent of hepatitis B virus (HBV) suppression and its association
with seroclearance of hepatitis ‘e’ antigen (HBeAg) and hepatitis B surface antigen (HBsAg…

Background Throughout the COVID-19 pandemic, testing individuals remains a key action.
One approach to rapid testing is to consider the olfactory capacities of trained detection dogs. …